A First-in-Human Study of the Safety of Single Continuous Intravenous (IV) Infusions of CXL-1427 for up to 48 Hours in Healthy Volunteers
Clinical trial NCT02819271 · COMPLETED
Trial details
- NCT number
- NCT02819271
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-01
- Primary completion
- 2014-04-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.